BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25807502)

  • 1. APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts.
    Niavarani A; Currie E; Reyal Y; Anjos-Afonso F; Horswell S; Griessinger E; Luis Sardina J; Bonnet D
    PLoS One; 2015; 10(3):e0120089. PubMed ID: 25807502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.
    Kim K; Shi AB; Kelley K; Chen XS
    J Mol Biol; 2023 Sep; 435(17):168198. PubMed ID: 37442413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages.
    Sharma S; Patnaik SK; Taggart RT; Kannisto ED; Enriquez SM; Gollnick P; Baysal BE
    Nat Commun; 2015 Apr; 6():6881. PubMed ID: 25898173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates.
    Tang G; Xie B; Hong X; Qin H; Wang J; Huang H; Hao P; Li X
    ACS Synth Biol; 2021 May; 10(5):1106-1115. PubMed ID: 33938211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adenosine-to-inosine tRNA-editing enzyme that can perform C-to-U deamination of DNA.
    Rubio MA; Pastar I; Gaston KW; Ragone FL; Janzen CJ; Cross GA; Papavasiliou FN; Alfonzo JD
    Proc Natl Acad Sci U S A; 2007 May; 104(19):7821-6. PubMed ID: 17483465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of possible WT1 RNA processing in primary Wilms tumors.
    Gunning KB; Cohn SL; Tomlinson GE; Strong LC; Huff V
    Oncogene; 1996 Sep; 13(6):1179-85. PubMed ID: 8808692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.
    Thielen BK; McNevin JP; McElrath MJ; Hunt BV; Klein KC; Lingappa JR
    J Biol Chem; 2010 Sep; 285(36):27753-66. PubMed ID: 20615867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.
    Sharma S; Patnaik SK; Kemer Z; Baysal BE
    RNA Biol; 2017 May; 14(5):603-610. PubMed ID: 27149507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-ω on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells.
    Wang Y; Li X; Song S; Sun Y; Zhang J; Yu C; Chen W
    Virol J; 2017 Nov; 14(1):211. PubMed ID: 29100527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.
    Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor protein (-KTS) modulates renin gene transcription.
    Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
    Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.
    Galimberti S; Guerrini F; Carulli G; Fazzi R; Palumbo GA; Morabito F; Petrini M
    Eur J Haematol; 2004 Jan; 72(1):45-51. PubMed ID: 14962262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC3A is a prominent cytidine deaminase in breast cancer.
    Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
    PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
    Kim YS; Sun S; Yoon JS; Ko YH; Won HS; Kim JS
    PLoS One; 2020; 15(3):e0230261. PubMed ID: 32176735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 gene expression lowered by IL-12 In vitro in peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes.
    Pan L; Zhang XJ; Niu ZY; Suo XH; Zhang JY; Yang L; Liu XJ; Qiao SK; Dong ZR; Ohno R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):501-7. PubMed ID: 16800930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant Wilms' tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD).
    Abbas S; Erpelinck-Verschueren CA; Goudswaard CS; Löwenberg B; Valk PJ
    Leukemia; 2010 Mar; 24(3):660-3. PubMed ID: 20016532
    [No Abstract]   [Full Text] [Related]  

  • 17. APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination.
    Ziegler SJ; Hu Y; Devarkar SC; Xiong Y
    Biochemistry; 2019 Sep; 58(37):3838-3847. PubMed ID: 31448897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.
    Bulliard Y; Narvaiza I; Bertero A; Peddi S; Röhrig UF; Ortiz M; Zoete V; Castro-Díaz N; Turelli P; Telenti A; Michielin O; Weitzman MD; Trono D
    J Virol; 2011 Feb; 85(4):1765-76. PubMed ID: 21123384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.
    Yamauchi T; Negoro E; Lee S; Takai M; Matsuda Y; Takagi K; Kishi S; Tai K; Hosono N; Tasaki T; Ikegaya S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Anticancer Res; 2013 Aug; 33(8):3335-40. PubMed ID: 23898100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.